Why the study?
Traditional TTE makes precise measurement of complex LA geometry challenging, while electroanatomic mapping offers a more accurate evaluation that may enhance prediction of AF recurrence after PVI.
Does the electric active volume of the left atrium assessed by electroanatomic mapping predict atrial fibrillation recurrence in patients undergoing pulmonary vein isolation?
Does the electric active volume of the left atrium assessed by electroanatomic mapping predict atrial fibrillation recurrence in patients undergoing pulmonary vein isolation?
Left atrial electric active volume measured by electroanatomic mapping correlates with echocardiographic measurements and independently predicts atrial fibrillation recurrence after pulmonary vein isolation.
Answers are grounded in this paper and cite their sources.
Electric active volume may aid post-PVI risk stratification; hypothesis-generating and should not yet change practice.
Background/Objectives: Catheter ablation for atrial fibrillation (AF) is a well-established therapeutic approach for maintaining sinus rhythm, though its efficacy remains suboptimal in certain patients. The left atrium (LA) volume, commonly assessed through transthoracic echocardiography (TTE), is a recognized predictor of AF recurrence after pulmonary vein isolation (PVI). However, the complex three-dimensional structure of the LA makes precise measurement challenging with traditional TTE techniques. Electroanatomic mapping (EAM) offers a more accurate evaluation of LA geometry and volume, which may enhance the prediction of ablation outcomes. Methods: This prospective study included 197 patients with AF who were referred for PVI to our center (Hospital Universitario Central de Asturias, Spain) between 2016 and 2020. All participants underwent pre-ablation TTE and EAM to assess the electric active volume (EAV) of the LA. Clinical follow-up included regular Holter monitoring and electrocardiograms to detect AF recurrences. Results: The mean age was 56.3 ± 9.67 years, and 34% had persistent AF. The mean LA volumes measured by TTE and the EAV by EAM were 62.86 ± 15.58 mL and 126.75 ± 43.35 mL, respectively, with a moderate positive correlation (r = 0.49, p < 0.001). AF recurrences were observed in 51.27% of patients over a 36 ± 15-month follow-up period. Cox regression analyses (univariate and multivariate), Kaplan–Meier curves and log-rank tests were used to illustrate freedom from atrial arrhythmia during follow-up. Both EAV by EAM and TTE volumes were significant predictors of AF recurrence in the univariate analysis (HR 1.002 [1.001–1.003], p = 0.033 and HR 1.001 [1.006–1.012], p < 0.01, respectively). Among clinical variables, persistent AF was significantly associated with a higher risk of recurrence (HR 1.17 [1.096–1.268], p = 0.02). Conclusions: EAV of the LA assessment by EAM demonstrates a significant correlation with TTE measurements and is a predictor of AF post-ablation recurrence. In patients selected for catheter ablation, EAV by EAM provides additional insights that could contribute to therapeutic decision-making and risk stratification of AF recurrences.
No takes yet. Share an insight, caveat, or question.
León et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: